France Anne-Laurence Sabatini, vice president of Cluster France, Canada & Benelux at LEO Pharma, discusses the transformation of the company and how this has trickled down to her cluster. Furthermore, she talks about the strategic importance of France and the steps LEO Pharma is taking to be the preferred medical dermatology…
Korea Rene Wipperich took the helm of Galderma’s Korean affiliate in August 2018. He breaks down the performance of the affiliate across its four business segments and the main competitive advantages of Galderma in Korea. He also explains the specificities of Korea, the importance of being present in what is a…
Egypt Amir Ghattas, senior director of the MENA cluster at LEO Pharma, highlights how the company is raising awareness for dermatological diseases in Egypt, having adopted a highly patient-centric focus. He also explains how LEO Pharma’s recent acquisitions and internal restructuration has benefitted the regional operations in the MENA cluster. …
Korea Dr Jino Park, founder and CEO of P&K Skin Research Centre, offers his assessment of the success of the Korean pharmaceutical industry, and the potential cosmetic products of the future. Dr Park also explains the added value P&K’s testing services bring to cosmetics producers. The global success of the ‘Hallyu’…
Spain Cédric Ertlé, general director of Laboratoires Expanscience Iberia, talks about his strategy to turn around the affiliate’s dermo cosmetic range in what is a shrinking Spanish market and his goal of introducing a rheumatology portfolio, as he did in Mexico. Furthermore, he discusses the importance of being a B-Corp company.…
Spain LEO Pharma’s Paolo Cionini discusses recent structural changes in the dermatology specialist’s Europe South operations, the importance of Spain to the regional group, and the nation’s digital capabilities. The biggest need in Europe and the US is around new products and technologies in advanced therapies. LEO Pharma has undergone…
Hong Kong Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate. Having had the experience of opening the affiliate in Brazil, in addition to your in-depth understanding of other emerging markets, what were the key skills you…
Hong Kong Frederic Charles, CEO of Pierre Fabre Hong Kong and Macau, outlines brand perceptions of Pierre Fabre’s dermatological products in Hong Kong, e-commerce, and other emerging skincare trends in Asia. With the opening of Pierre Fabre Hong Kong affiliate in 2016, what were the main achievements so far? The affiliate…
Algeria Nawel Baba Hamed, general director of Pierre Fabre Algeria, outlines the French company’s product portfolio in Algeria, its dermatological expertise, and the growing significance of its oncology segment. Could you introduce our readers to Pierre Fabre and its footprint in Algeria? Pierre Fabre is the second-largest dermo-cosmetic laboratory in…
Turkey Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare system could benefit from critical products which are not often considered to have strong ties to preventative care. Can…
India Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and non-sterile semi-solid products in the dermatology and ophthalmology arenas, provides insights into the international development of his ambitious company in 40+ export markets. In line with the recent set up of Galentic’s new manufacturing…
Poland Philippe Coudiere, general manager of Pierre Fabre Dermo-cosmetics Poland, highlights the key partnerships the company has nurtured with pharmacists and dermatologists and the importance of clinical data for their products. Furthermore, he explains the need to develop a strong connection with end consumers and the dynamics of the Polish dermo-cosmetic…
See our Cookie Privacy Policy Here